Editorial: CAR T-Cell Therapies in Hematologic Tumors

Marta Coscia; Benedetto Bruno; Sattva Neelapu

doi:10.3389/fonc.2020.588134

Editorial: CAR T-Cell Therapies in Hematologic Tumors

Front Oncol. 2020 Oct 16:10:588134. doi: 10.3389/fonc.2020.588134. eCollection 2020.

Authors

Marta Coscia¹, Benedetto Bruno¹, Sattva Neelapu²

Affiliations

¹ University Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, and Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
² Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

No abstract available

Keywords: B-cell non-Hodgkin lymphoma (B-NHL); CAR T-Cell therapies; CAR T-cell toxicities; acute lymphoblastic leukemia; acute myeloid leukemia (AML); chimeric antigen receptors; chronic lymphocytic leukemia; multiple myeloma.

Publication types

Editorial

Grants and funding

P30 CA016672/CA/NCI NIH HHS/United States